Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), relating to its proposed merger with MEI Pharma, Inc.. Under the terms of the agreement, INFI shareholders are expected to own approximately 42% of the newly combined company.
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), relating to its proposed merger with MEI Pharma, Inc.. Under the terms of the agreement, INFI shareholders are expected to own approximately 42% of the newly combined company.